USD 303.32
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 90.46 Billion CHF | 2.63% |
2022 | 88.15 Billion CHF | -4.51% |
2021 | 92.31 Billion CHF | 7.17% |
2020 | 86.13 Billion CHF | 3.67% |
2019 | 83.09 Billion CHF | 5.83% |
2018 | 78.51 Billion CHF | 2.4% |
2017 | 76.67 Billion CHF | -0.19% |
2016 | 76.81 Billion CHF | 1.39% |
2015 | 75.76 Billion CHF | 0.16% |
2014 | 75.64 Billion CHF | 21.67% |
2013 | 62.16 Billion CHF | -4.07% |
2012 | 64.8 Billion CHF | 5.24% |
2011 | 61.57 Billion CHF | 0.91% |
2010 | 61.02 Billion CHF | -18.17% |
2009 | 74.56 Billion CHF | -2.0% |
2008 | 76.08 Billion CHF | -2.68% |
2007 | 78.18 Billion CHF | 5.06% |
2006 | 74.41 Billion CHF | 7.28% |
2005 | 69.36 Billion CHF | 19.44% |
2004 | 58.07 Billion CHF | -2.37% |
2003 | 59.48 Billion CHF | -7.05% |
2002 | 63.99 Billion CHF | -15.0% |
2001 | 75.28 Billion CHF | 8.27% |
2000 | 69.53 Billion CHF | -1.27% |
1999 | 70.43 Billion CHF | 26.04% |
1998 | 55.87 Billion CHF | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 95.78 Billion CHF | 0.0% |
2024 Q1 | 95.78 Billion CHF | 5.88% |
2023 Q2 | 84.37 Billion CHF | 0.0% |
2023 FY | 90.46 Billion CHF | 2.63% |
2023 Q3 | 90.46 Billion CHF | 7.23% |
2023 Q4 | 90.46 Billion CHF | 0.0% |
2023 Q1 | 84.37 Billion CHF | -4.29% |
2022 Q4 | 88.15 Billion CHF | 0.0% |
2022 FY | 88.15 Billion CHF | -4.51% |
2022 Q1 | 86.73 Billion CHF | -6.05% |
2022 Q2 | 86.73 Billion CHF | 0.0% |
2022 Q3 | 88.15 Billion CHF | 1.63% |
2021 Q4 | 92.31 Billion CHF | 0.0% |
2021 Q3 | 92.31 Billion CHF | 5.04% |
2021 Q2 | 87.88 Billion CHF | 0.0% |
2021 Q1 | 87.88 Billion CHF | 2.03% |
2021 FY | 92.31 Billion CHF | 7.17% |
2020 Q1 | 80.36 Billion CHF | -3.28% |
2020 FY | 86.13 Billion CHF | 3.67% |
2020 Q3 | 86.13 Billion CHF | 7.19% |
2020 Q4 | 86.13 Billion CHF | 0.0% |
2020 Q2 | 80.36 Billion CHF | 0.0% |
2019 Q3 | 83.09 Billion CHF | 3.61% |
2019 Q4 | 83.09 Billion CHF | 0.0% |
2019 FY | 83.09 Billion CHF | 5.83% |
2019 Q2 | 80.19 Billion CHF | 0.0% |
2019 Q1 | 80.19 Billion CHF | 2.14% |
2018 Q1 | 78.17 Billion CHF | 1.95% |
2018 Q3 | 78.51 Billion CHF | 0.44% |
2018 FY | 78.51 Billion CHF | 2.4% |
2018 Q2 | 78.17 Billion CHF | 0.0% |
2018 Q4 | 78.51 Billion CHF | 0.0% |
2017 Q4 | 76.67 Billion CHF | 0.0% |
2017 FY | 76.67 Billion CHF | -0.19% |
2017 Q3 | 76.67 Billion CHF | 6.72% |
2017 Q2 | 71.84 Billion CHF | 0.0% |
2017 Q1 | 71.84 Billion CHF | -6.47% |
2016 Q2 | 74.51 Billion CHF | 0.0% |
2016 Q1 | 74.51 Billion CHF | -1.65% |
2016 Q3 | 76.81 Billion CHF | 3.09% |
2016 Q4 | 76.81 Billion CHF | 0.0% |
2016 FY | 76.81 Billion CHF | 1.39% |
2015 FY | 75.76 Billion CHF | 0.16% |
2015 Q2 | 68.89 Billion CHF | 0.0% |
2015 Q4 | 75.76 Billion CHF | 0.0% |
2015 Q3 | 75.76 Billion CHF | 9.97% |
2015 Q1 | 68.89 Billion CHF | -8.92% |
2014 Q1 | 61.96 Billion CHF | -0.32% |
2014 Q3 | 75.54 Billion CHF | 21.9% |
2014 Q2 | 61.96 Billion CHF | 0.0% |
2014 FY | 75.64 Billion CHF | 21.67% |
2014 Q4 | 75.64 Billion CHF | 0.13% |
2013 FY | 62.16 Billion CHF | -4.07% |
2013 Q2 | 59.41 Billion CHF | 0.0% |
2013 Q4 | 62.16 Billion CHF | 0.0% |
2013 Q3 | 62.16 Billion CHF | 4.63% |
2013 Q1 | 59.41 Billion CHF | -8.32% |
2012 Q4 | 64.8 Billion CHF | 0.0% |
2012 Q2 | 59.6 Billion CHF | 0.0% |
2012 FY | 64.8 Billion CHF | 5.24% |
2011 Q2 | 55.29 Billion CHF | 0.0% |
2011 FY | 61.57 Billion CHF | 0.91% |
2011 Q4 | 61.57 Billion CHF | 0.0% |
2010 FY | 61.02 Billion CHF | -18.17% |
2010 Q2 | 63.85 Billion CHF | 0.0% |
2010 Q4 | 61.02 Billion CHF | 0.0% |
2009 Q4 | 74.56 Billion CHF | 0.0% |
2009 Q2 | 76.63 Billion CHF | 0.0% |
2009 FY | 74.56 Billion CHF | -2.0% |
2008 Q2 | 70.69 Billion CHF | 0.0% |
2008 FY | 76.08 Billion CHF | -2.68% |
2008 Q4 | 76.08 Billion CHF | 0.0% |
2007 Q2 | 76.61 Billion CHF | 0.0% |
2007 FY | 78.18 Billion CHF | 5.06% |
2007 Q4 | 78.18 Billion CHF | 0.0% |
2006 Q4 | 74.41 Billion CHF | 0.0% |
2006 FY | 74.41 Billion CHF | 7.28% |
2005 FY | 69.36 Billion CHF | 19.44% |
2004 FY | 58.07 Billion CHF | -2.37% |
2003 FY | 59.48 Billion CHF | -7.05% |
2002 FY | 63.99 Billion CHF | -15.0% |
2001 FY | 75.28 Billion CHF | 8.27% |
2000 FY | 69.53 Billion CHF | -1.27% |
1999 FY | 70.43 Billion CHF | 26.04% |
1998 FY | 55.87 Billion CHF | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AstraZeneca PLC | 100.97 Billion USD | 10.407% |
Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | 4.93% |
CSPC Pharmaceutical Group Limited | 6.52 Billion USD | -1286.692% |
Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -174859.387% |
Novartis AG | 99.94 Billion USD | 9.482% |
PT Kalbe Farma Tbk. | 1.75 Billion USD | -5043.904% |